Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Early and Degressive Putamen Atrophy in Multiple Sclerosis.
Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune mediated neuropathies.
Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
Evoked potentials in multiple sclerosis.
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge.
Beneficial effects of UV radiation other than via vitamin D production.
Relevance of brain lesion location to cognition in relapsing multiple sclerosis.
Frequency of reported European ancestry among multiple sclerosis patients from four cities in the southern and southeastern regions of Brazil.
Association of circulating follicular helper T cells with disease course of NMO spectrum disorders.
Neuroendocrine Responses to Transvascular Autonomic Modulation: A Modified Balloon Angioplasty in Multiple Sclerosis Patients.
Using Twitter to investigate opinions about multiple sclerosis treatments: a descriptive, exploratory study.
An update on new and emerging therapies for relapsing-remitting multiple sclerosis.
Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia.
Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis.
Pelizaeus-Merzbacher disease-associated proteolipid protein 1 inhibits oligodendrocyte precursor cell differentiation via extracellular-signal regulated kinase signaling.
Leuprolide Acetate, a GnRH Agonist, Improves Experimental Autoimmune Encephalomyelitis: A Possible Therapy for Multiple Sclerosis.
Vascular pathology of multiple sclerosis.
Resistance training and vibration improve muscle strength and functional capacity in female patients with multiple sclerosis.
Mitochondrial Complex Enzyme Activities and Cytochrome c Expression Changes in Multiple Sclerosis.
Autoimmune neurological disorders associated with group-A beta-hemolytic streptococcal infection.
Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients.
Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.
Protective Role of (RS )-glucoraphanin Bioactivated with Myrosinase in an Experimental Model of Multiple Sclerosis.
Brain Plasticity Effects of Neuromodulation Against Multiple Sclerosis Fatigue.
Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders.
Pages
« first
‹ previous
…
322
323
324
325
326
327
328
329
330
…
next ›
last »